BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Sai Life Sciences Ltd. IPO

IPO Date: Dec 11 to Dec 13 2024

Listing Date: Dec 18 2024

Objective

1. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company; and
2. General corporate purposes.

IPO Details

Face Value ₹ 1.00 Per Share
Issue Size ₹ 2026.92 - 2131.76 Cr
Price Band ₹ 522.00 - ₹ 549.00 Per Share
Market LOT 27 shares
Issue Type Book building

About Company

We are an innovator-focused, contract research, development, and manufacturing organization (“CRDMO”). We provide end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (“NCE”), to global pharmaceutical innovator companies and biotechnology firms. We possess both (a) discovery / contract research (“CRO”) and (b) chemistry, manufacturing, and control (“CMC”) / contract development and manufacturing organization (“CDMO”) capabilities. We are the fastest-growing Indian CRDMOs among listed Indian peers in terms of revenue .... CAGR as well as EBITDA CAGR from Financial Year 2022 to Financial Year 2024. (Source: F&S Report) Our CRDMO platform provides multiple entry points for us to acquire customers in the intermediate stages of their new drug discovery to commercialization journey. We are also one of the few CRDMOs to have a unique delivery model of having research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (“US”) and Manchester, United Kingdom (“UK”), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India. (Source: F&S Report) During the Financial Year 2024, we served more than 280 innovator pharmaceutical companies, including 18 of the top 25 pharmaceutical companies (in terms of revenue for the calendar year 2023), across regulated markets, including the US, the UK, Europe and Japan. (Source: F&S Report) During the Financial Year 2024, we also provided CRO services to more than 60 customers on an ongoing basis, for their integrated drug discovery programs. As of March 31, 2024, our CDMO product portfolio included more than 150 innovator pharmaceutical products, including 38 products that were supplied for manufacturing of 28 commercial drugs. Read More
Address

Plot No. D S-7, I K P Knowledge Park Turkapally Village, Shameerpet Mandal Medchal- Malkajgiri District

City

Hyderabad

State

Telangana

Pincode

500078

Phone

040-68156000

Email

info@sailife.com

Website

www.sailife.com

About IPO

Listed At BSE/NSE
Lead Manager Morgan Stanley India Co Pvt Ltd
Promoters
Kanumuri Ranga Raju
Krishnam Raju Kanumuri
Kanumuri Mytreyi
Sai Quest Syn Pvt Ltd.
Marigold Partners
Sunflower Partners
Tulip Partners and Lily Partners

Promoter's Holding

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

040 - 67162222/18003094001
einward.ris@kfintech.com
www.kfintech.com

Latest News

Sep
17
2026
EQUITY Posted on Sep 17th 2026

Sai Life Sciences informs about outcome of AGM

Pursuant to Regulation 30 of the SEBI Listing Regulations, Sai Life Sciences has enclosed the summary of proceedings of the 27th AGM of the members of Sai Life Sciences held on Thursday, September 17, 2026, at 10:30 AM (IST), through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
1
2026
EQUITY Posted on Sep 1st 2026

Sai Life Sciences informs about allotment of equity shares under ESOP

Sai Life Sciences has informed that, pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations the Board of Directors by the way of Circular Resolution on 01st September 2026, had approved the allotment of 14,600 and 66,000 fully paid-up equity shares having a face value of ₹1 each upon exercise of options granted under ESOP 2008 and MESOP 2018 respectively. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from ₹21,23,13,617 to ₹21,23,94,216. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (‘SEBI ESOP Regulations 2021’) are enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Read More
Sep
19
2026
EQUITY Posted on Sep 19th 2026

K&R Rail Engineering informs about AGM

K&R Rail Engineering has informed that the Registrar of Companies (ROC), Hyderabad, has approved the Company's application seeking an extension of time for holding its Annual General Meeting (AGM) for the financial year ended March 31, 2026. The ROC, vide its approval letter dated September 05, 2026 (copy enclosed), has granted a three-month extension to hold the AGM. Consequently, the AGM, which was originally required to be held on or before September 30, 2026, may now be convened within the extended timeline. The specific date, time, and venue of the upcoming AGM will be determined by the Board of Directors of the Company and communicated to the Exchange in due course.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
19
2026
EQUITY Posted on Sep 19th 2026

East India Drums and Barrels Manufacturing informs about award of contract

East India Drums and Barrels Manufacturing has informed that East India Drums & Barrels Manufacturing has been awarded a contract through the Government e-Marketplace (GeM) from the Hindustan Petroleum Corporation, Ministry of Petroleum and Natural Gas, Central PSU.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
19
2026
EQUITY Posted on Sep 19th 2026

RailTel Corporation of India informs about updates

RailTel Corporation of India has informed that RailTel Corporation of India (the Company) had received the demand notice from the Assistant Commissioner, CGST & СХ, Itanagar Division in the form of DRC-07 vide Order No ZD1212250004429 dated 15/01/2026. As per the order there was a total penalty amount of Rs. 49.24 Lakhs; Further inform that the Additional Commissioner of Appeals, CGST & CX, Guwahati vide ORDER-IN-APPEAL No. 33UGHY(A)/ADC/CGSr/rrA/ 2026 and DIN- 20260870A000003C762E dated 10- 08-2026 (received on 18/09/2026), has set aside the above demand notice. The requisite details as per SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Sai Life Sciences Ltd. IPO?

The issue size of Sai Life Sciences Ltd. IPO is ₹2026.92 - 2131.76 crore.

The Sai Life Sciences Ltd. IPO opens for subscription on 2024-12-11 and closes on 2024-12-13.

The price range of Sai Life Sciences Ltd. IPO is ₹522.00 to ₹549.00.

The lot size of Sai Life Sciences Ltd. IPO is 27 shares.

The registrar of Sai Life Sciences Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).

Sai Life Sciences Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2024-12-13 to increase your chances.

The listing date of Sai Life Sciences Ltd. IPO is 2024-12-18.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore